IL1B and metabolic dysfunction-associated steatotic liver disease: From an immunologic standpoint, these cytokines may have contributed to the development of steatosis particularly IL-1 Beta and TNF-alpha, which have been identified to be significantly associated with increased risk of Non-Alcoholic Fatty Liver Disease (NAFLD) (37).